← Back to Search

Behavioural Intervention

Cooling Agent Cigarettes for Tobacco Addiction

N/A
Waitlist Available
Led By Eleanor Leavens, PhD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 21 years old
Be older than 18 years old
Must not have
Current use of cessation medications
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to understand what menthol cigarette smokers think of "non-menthol cooling cigarettes" that tobacco companies are marketing in place of menthol cigarettes. Researchers want to learn how these new cigarettes

Who is the study for?
This trial is for adult smokers who currently use menthol cigarettes and are interested in comparing traditional, menthol, and non-menthol cooling agent cigarettes. Specific eligibility criteria details were not provided.
What is being tested?
The study investigates the preferences of menthol cigarette smokers by having them try three types of cigarettes: traditional tobacco, menthol, and new non-menthol with a cooling agent to see how they impact smoking habits.
What are the potential side effects?
Since this trial involves smoking different types of cigarettes rather than taking medication or undergoing treatment, side effects may include those typically associated with tobacco use such as increased risk for respiratory issues and cardiovascular disease.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 21 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently using medication to help me stop smoking.
Select...
I am unable to understand or sign the consent form.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cigarette changes from baseline to week 3

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Traditional non-menthol cigarette smokingExperimental Treatment1 Intervention
Current menthol smokers will be assigned to smoke study provided traditional non-menthol cigarettes.
Group II: Synthetic cooling agent cigarette smokingExperimental Treatment1 Intervention
Current menthol smokers will be assigned to smoke study provided synthetic cooling agent cigarettes.
Group III: Continued menthol smokingActive Control1 Intervention
Current menthol smokers will be assigned to smoke study provided menthol cigarettes.

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
506 Previous Clinical Trials
174,306 Total Patients Enrolled
Eleanor Leavens, PhDPrincipal InvestigatorUniversity of Kansas Medical Center
2 Previous Clinical Trials
70 Total Patients Enrolled
~0 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top